Market Research Logo

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015

Introduction
Global Markets Direct Report Coverage
Chagas Disease (American Trypanosomiasis) Overview
Therapeutics Development
Pipeline Products for Chagas Disease (American Trypanosomiasis) - Overview
Pipeline Products for Chagas Disease (American Trypanosomiasis) - Comparative Analysis
Chagas Disease (American Trypanosomiasis) - Therapeutics under Development by Companies
Chagas Disease (American Trypanosomiasis) - Therapeutics under Investigation by Universities/Institutes
Chagas Disease (American Trypanosomiasis) - Pipeline Products Glance
Clinical Stage Products
Early Stage Products
Chagas Disease (American Trypanosomiasis) - Products under Development by Companies
Chagas Disease (American Trypanosomiasis) - Products under Investigation by Universities/Institutes
Chagas Disease (American Trypanosomiasis) - Companies Involved in Therapeutics Development
Anacor Pharmaceuticals, Inc.
Eisai Co., Ltd.
Grupo Praxis Pharmaceutical SA
Merck & Co., Inc.
Panacela Labs, Inc.
Sanofi
SEEK Group
Chagas Disease (American Trypanosomiasis) - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
benznidazol - Drug Profile
Product Description
Mechanism of Action
R&D Progress
chagas disease (bivalent) vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
chagas disease vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
chagas disease vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
chagas disease vaccine - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cz-007 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cz-008 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
EPLBS-1246 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
EPLBS-967 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
fexinidazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
fosravuconazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
K-777 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
LH-7 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Monoclonal Antibody for Chagas - Drug Profile
Product Description
Mechanism of Action
R&D Progress
NEU-321 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
posaconazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit Cruzipain for Chagas Disease - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecule to Inhibit SOD for Chagas Disease and Leishmaniasis - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Chagas Disease - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Chagas Disease - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Chagas Disease - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Chagas Disease - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Chagas Disease - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Infectious Diseases - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Infectious Diseases - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules for Protozoal Infections - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Lanosterol 14 alpha-Demethylase for Chagas Disease - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Small Molecules to Inhibit Proline Racemase for Chagas Disease - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Vaccine for Chagas Disease - Drug Profile
Product Description
Mechanism of Action
R&D Progress
VNI - Drug Profile
Product Description
Mechanism of Action
R&D Progress
XELRYX-3 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Chagas Disease (American Trypanosomiasis) - Recent Pipeline Updates
Chagas Disease (American Trypanosomiasis) - Dormant Projects
Chagas Disease (American Trypanosomiasis) - Discontinued Products
Chagas Disease (American Trypanosomiasis) - Product Development Milestones
Featured News & Press Releases
Dec 26, 2013: New Drug Candidates Show Promise for Cure for Chagas Disease
Nov 14, 2013: Drug Trial for Leading Parasitic Killer of the Americas Shows Mixed Results but Provides New Evidence for Improved Therapy
May 03, 2013: Funding boost for GSK’s open innovation research into diseases affecting the developing world
Apr 30, 2012: NYU School of Medicine Receives Support From The Tres Cantos Open Lab Foundation To Discover New Drugs Against Chagas Disease
Mar 12, 2012: DNDi Receives €2m Strategic Translation Award From Wellcome Trust To Develop New Drug Against Chagas Disease
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Chagas Disease (American Trypanosomiasis), H2 2015
Number of Products under Development for Chagas Disease (American Trypanosomiasis) - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015 (Contd...1)
Comparative Analysis by Clinical Stage Development, H2 2015
Comparative Analysis by Early Stage Development, H2 2015
Products under Development by Companies, H2 2015
Products under Investigation by Universities/Institutes, H2 2015
Products under Investigation by Universities/Institutes, H2 2015 (Contd...1)
Chagas Disease (American Trypanosomiasis) - Pipeline by Anacor Pharmaceuticals, Inc., H2 2015
Chagas Disease (American Trypanosomiasis) - Pipeline by Eisai Co., Ltd., H2 2015
Chagas Disease (American Trypanosomiasis) - Pipeline by Grupo Praxis Pharmaceutical SA, H2 2015
Chagas Disease (American Trypanosomiasis) - Pipeline by Merck & Co., Inc., H2 2015
Chagas Disease (American Trypanosomiasis) - Pipeline by Panacela Labs, Inc., H2 2015
Chagas Disease (American Trypanosomiasis) - Pipeline by Sanofi, H2 2015
Chagas Disease (American Trypanosomiasis) - Pipeline by SEEK Group, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Stage and Target, H2 2015
Number of Products by Stage and Mechanism of Action, H2 2015
Number of Products by Stage and Route of Administration, H2 2015
Number of Products by Stage and Molecule Type, H2 2015
Chagas Disease (American Trypanosomiasis) Therapeutics - Recent Pipeline Updates, H2 2015
Chagas Disease (American Trypanosomiasis) - Dormant Projects, H2 2015
Chagas Disease (American Trypanosomiasis) - Discontinued Products, H2 2015
List of Figures
Number of Products under Development for Chagas Disease (American Trypanosomiasis), H2 2015
Number of Products under Development for Chagas Disease (American Trypanosomiasis) - Comparative Analysis, H2 2015
Number of Products under Development by Companies, H2 2015
Number of Products under Investigation by Universities/Institutes, H2 2015
Comparative Analysis by Early Stage Products, H2 2015
Assessment by Monotherapy Products, H2 2015
Number of Products by Targets, H2 2015
Number of Products by Stage and Targets, H2 2015
Number of Products by Mechanism of Actions, H2 2015
Number of Products by Stage and Mechanism of Actions, H2 2015
Number of Products by Routes of Administration, H2 2015
Number of Products by Stage and Routes of Administration, H2 2015
Number of Products by Molecule Types, H2 2015
Number of Products by Stage and Molecule Types, H2 2015

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015

Summary

Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015’, provides an overview of the Chagas Disease (American Trypanosomiasis)’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Chagas Disease (American Trypanosomiasis), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Chagas Disease (American Trypanosomiasis) and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global therapeutic landscape of Chagas Disease (American Trypanosomiasis)
  • The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved in the therapeutics development for Chagas Disease (American Trypanosomiasis) and enlists all their major and minor projects
  • The report summarizes all the dormant and discontinued pipeline projects
  • A review of the Chagas Disease (American Trypanosomiasis) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
  • Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • A detailed assessment of monotherapy and combination therapy pipeline projects
  • Coverage of the Chagas Disease (American Trypanosomiasis) pipeline on the basis of target, MoA, route of administration and molecule type
  • Latest news and deals relating related to pipeline products
Reasons to buy
  • Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop strategic initiatives by understanding the focus areas of leading companies
  • Identify and understand important and diverse types of therapeutics under development for Chagas Disease (American Trypanosomiasis)
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Devise corrective measures for pipeline projects by understanding Chagas Disease (American Trypanosomiasis) pipeline depth and focus of Indication therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;